Tolebrutinib

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

TOLEBRUTINIB CRYSTAL FORM, AMORPHOUS FORM, PREPARATION METHOD THEREFOR AND USE THEREOF
EP 4328226 A4申请人: HANGZHOU SOLIPHARMA CO LTD优先权: 2021
CN
EP
US
WO
5 件公开
Crystalline form of Tolebrutinib
US 12049463 B2申请人: GENZYME CORP优先权: 2020
EP
US
WO
5 件公开
METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS BY DETECTING A BIOMARKER IN THE CEREBROSPINAL FLUID
US 20250354998 A1申请人: PRINCIPIA BIOPHARMA INC优先权: 2023
US
WO
2 件公开
Methods of Making Tolebrutinib
- US 20250282777 A1
  申请人: PRINCIPIA BIOPHARMA INC优先权: 2024
  US
  WO
  2 件公开
- US 20250101021 A1
  申请人: PRINCIPIA BIOPHARMA INC优先权: 2024
  US
TOLEBRUTINIB SALT AND CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF
EP 4342468 A4申请人: HANGZHOU SOLIPHARMA CO LTD优先权: 2021
EP
Crystal Form of Tolebrutinib, Preparation Method Therefor and Use Thereof
US 20250034130 A1申请人: PRINCIPIA BIOPHARMA INC优先权: 2021
US
SOLID STATE FORMS OF TOLEBRUTINIB AND OF TOLEBRUTINIB SALTS
US 20250188076 A1申请人: TEVA PHARMACEUTICAL INT GMBH优先权: 2023
US
TOLEBRUTINIB FOR MULTIPLE SCLEROSIS
WO 2026050513 A1申请人: PRINCIPIA BIOPHARMA INC优先权: 2024
WO